Ultrahuman, the Bengaluru-based maker of the Ultrahuman Ring, announced a $70m financing round on 3 September 2026. Qualcomm Ventures took part alongside US diagnostics company Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners and Alteria Capital. The company did not name a lead investor.
Founder and chief executive Mohit Kumar told TechCrunch that the round was made up of $65m in primary equity and $5m in debt.
The round values Ultrahuman at $365m, a person familiar with the matter told TechCrunch. That would be about three times the $120m valuation the company had in 2023, according to the same report. Ultrahuman did not disclose a valuation in its own announcement.
“By combining longitudinal wearable data with deeper biological signals, Ultrahuman is creating new opportunities in personalized health.”Megann Vaughn Watters, Vice President and Head of Labcorp Venture Fund and Strategic Alliances, Labcorp
What Ultrahuman does
Kumar and Vatsal Singhal co-founded Ultrahuman in 2019. It started with continuous glucose monitors for tracking metabolic health before moving into smart rings, which now make up most of its business, TechCrunch reported. Its range includes the Ring Air and Ring Pro, the Blood Vision blood-testing service, the M1 and M2 Live glucose monitors, the Ultrahuman Home sleep-environment device and PowerPlugs, its paid software add-ons.
Kumar told TechCrunch that the company was at an annual revenue run rate of $140m, up about 45% on a year earlier, and expected to reach $200m by January 2027. He said Ultrahuman had sold around 800,000 rings, up from about 700,000 in February, and that about 12% of users paid for PowerPlugs.
The US is the company's largest market, at about 45% of revenue this quarter, with India at about 11%, Kumar said. Ultrahuman stopped selling the Ring Air in the US for much of the past year after a patent dispute with rival Oura, and returned this year with a redesigned Ring Pro.
Qualcomm and Labcorp
Kumar told TechCrunch that Ultrahuman was working with Qualcomm on a new ring that will use Qualcomm silicon, alongside the Nordic Semiconductor chips it already uses. More computing power on the ring would let more software run on the device instead of on a phone or in the cloud. The company is looking at uses such as a pointer, a game controller, a car key and a way to interact with AI apps, and some of these features were due to reach existing rings through a software update by the end of September.
Quinn Li, global head of Qualcomm Ventures, said in the announcement that the future of AI was personal, ambient and always on.
With Labcorp, Ultrahuman is exploring whether blood-flow signals from the ring, combined with blood-test data, can help flag risks in areas such as cardiovascular health, fertility and ageing, Kumar told TechCrunch. He declined to give details of any product integration.
What the money is for
The company said it would spend on research and development in sensing, AI, miniaturised electronics and health algorithms, expand its clinical research, extend Blood Vision and its metabolic health platform, and grow internationally. Kumar told TechCrunch that some of the money would go into offline sales in markets such as India and the UAE.
That spending means Ultrahuman may not be profitable this year, Kumar said. He told TechCrunch the company wants about eight quarters of profitability before going public and sees 2028 as the earliest window for an IPO.
The funding so far
According to Wikipedia's summary of the company's funding, Ultrahuman previously raised a $7.5m seed round and a $17.5m Series A, followed by a $35m Series B in March 2024 that was co-led by Blume Ventures, Steadview Capital and Nexus Venture Partners. The company did not give a total for funding to date.
Company website: ultrahuman.com